Australia Near Deal On IP Policy For Pharmaceuticals

Law360, New York (August 6, 2004, 12:00 AM EDT) -- Australia’s conservative government and the opposition Labor Party are near an agreement that would break a stalemate over intellectual-property provisions in the country’s recently negotiated free trade agreement with the U.S., according to media reports.

The agreement, which would require parliamentary approval to take effect from January, has been stalled by disagreements over demands by the Labor opposition for measures to protect Australia's cheap pharmaceutical drugs scheme.

Labor leader Mark Latham has demanded an amendment to free trade legislation to prevent U.S. pharmaceutical companies from using...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.